INMB – inmune bio inc. - common stock (US:NASDAQ)
Stock Stats
News
INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives
INmune Bio (NASDAQ:INMB) was upgraded by analysts at Wall Street Zen
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595's Evidence Base in High-Inflammation Alzheimer's Patients [Yahoo! Finance]
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients
Form 8-K Inmune Bio, Inc. For: Jan 27
Form 8-K Inmune Bio, Inc. For: Dec 22
Form 8-K Inmune Bio, Inc. For: Dec 19
Form 424B5 Inmune Bio, Inc.
Form 8-K Inmune Bio, Inc. For: Dec 05
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.